Seran Bioscience, LLC
Bend, OR 97701 · Manufacturing · EIN 81-1752632
2025 plan yearFully insured
Seran Bioscience, LLC (Bend, OR, 188 participants) has a fully insured health plan with Blue Cross Blue Shield (all plans). Its brokers of record are Cobbs Allen Capital and Mark Stephen Mettille, paid 5.8% of reported premium (median for this size: 4.4%). Coverage renews in January.
Participants
188
Renews
Jan
Schedule A premium
$2.1M
Broker comp
$120K
Comp rate
5.8%
Carriers by line
Insurance contracts (Schedule A)
| Lines | Carrier | Policy year | Covered | Premium | Broker comp | Comp rate | Paid to |
|---|---|---|---|---|---|---|---|
| Rx, Medical | Blue Cross Blue Shield (all plans) | Jan 1, 2025 to Dec 31, 2025 |
324 | $1,792,687 | $52,200 | 2.9% typical · median 4.4% |
Cobbs Allen Capital |
| Accident, AD&D, LTD, Critical Illness, STD, Life, Hospital Indemnity, Vision, Dental Accidental Death and Dismemberment, Accident, Critical Illness, Hospital |
Guardian | Jan 1, 2025 to Dec 31, 2025 |
188 | $263,856 | $68,009 | 26% above typical · median 11% |
Cobbs Allen Capital Mark Stephen Mettille |
Brokers and agents paid
| Firm | Location | Contracts | Commissions + fees |
|---|---|---|---|
| Cobbs Allen Capital | Birmingham, AL | 2 | $106,092 |
| Mark Stephen Mettille | Saint Petersburg, FL | 1 | $14,117 |
Plan-year history, 2023–2025
| Plan year | Participants | Premium | Broker comp | Medical funding | Top carriers | Brokers |
|---|---|---|---|---|---|---|
| 2025 | 188 | $2.1M | $120K | Fully insured | Blue Cross Blue Shield (all plans), Guardian | Cobbs Allen Capital, Mark Stephen Mettille |
| 2024 | 196 | $1.8M | $56K | Fully insured | Blue Cross Blue Shield (all plans), Guardian | Cobbs Allen Hall |
| 2023 | 188 | $1.8M | $85K | Fully insured | Blue Cross Blue Shield (all plans), MetLife | Cobbs Allen and Hall |
Across all of this employer's welfare plans, as filed. Years with missing or partial filings show smaller totals.
Health and welfare plans
| Plan # | Plan | Plan year | Participants | Received | Original |
|---|---|---|---|---|---|
| 503 | Seran Bioscience Benefit Plan | Jan 1, 2025 – Dec 31, 2025 | 188 | Jul 29, 2026 | Filing PDF |
Data as filed with the U.S. Department of Labor, through Oct 24, 2026. Something wrong? Report a data issue.